Yan Moore, M.D. joined ARIAD as Vice President, Medical Affairs, in April 2014.
Prior to joining ARIAD, from July 2011 until April 2014, Dr. Moore served as associate vice president of global medical affairs at Sanofi. There, he was responsible for Global Medical Affairs, clinical development and business opportunities for company’s gastro-intestinal and other solid tumor products.
He previously held the executive director of oncology clinical development position at GlaxoSmithKline from August 2009 to July 2011, where he focused on the clinical development for the lapatinib program. Dr. Moore joined GSK from Bristol Myers-Squibb, where from 2007 to 2009 he was the erbitux™ development group director and a global GI cancer development lead across the oncology portfolio. Before joining BMS Dr. Moore headed the Medical Affairs group at GPC biotech, Inc. with wide development responsibilities for the development of Satraplatin™ for prostate cancer. Prior to GPC Biotech, he was the global medical director for Urology and GU oncology for GE Healthcare (ONCURA) from 2003 to 2006.
Dr. Moore earned a Bachelor of Science and M.D. degrees from the Sackler School of Medicine in Tel Aviv, Israel. He completed his internship in internal medicine at the Edith Wolfson Medical Center and a residency program in Ob/Gyn. He received his MBA from the LeBow College of Business at Drexel University in Philadelphia.